Qingran Yan

684 total citations
34 papers, 457 citations indexed

About

Qingran Yan is a scholar working on Rheumatology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Qingran Yan has authored 34 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 10 papers in Pathology and Forensic Medicine and 10 papers in Immunology. Recurrent topics in Qingran Yan's work include Systemic Lupus Erythematosus Research (9 papers), Systemic Sclerosis and Related Diseases (9 papers) and Dermatologic Treatments and Research (5 papers). Qingran Yan is often cited by papers focused on Systemic Lupus Erythematosus Research (9 papers), Systemic Sclerosis and Related Diseases (9 papers) and Dermatologic Treatments and Research (5 papers). Qingran Yan collaborates with scholars based in China, United States and Australia. Qingran Yan's co-authors include Qiong Fu, Chunde Bao, Xinfang Huang, Jie Chen, Wei Li, Xiaodong Wang, Fang Du, Liangjing Lu, Sheng Chen and Qiang Guo and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Qingran Yan

31 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingran Yan China 13 151 140 122 76 69 34 457
Paola Adele Lonati Italy 12 66 0.4× 184 1.3× 191 1.6× 163 2.1× 43 0.6× 21 481
Stinne Ravn Greisen Denmark 13 122 0.8× 158 1.1× 266 2.2× 52 0.7× 60 0.9× 36 622
Tatjana Terzić Serbia 12 156 1.0× 41 0.3× 61 0.5× 69 0.9× 51 0.7× 50 561
Ryo Hisada Japan 14 107 0.7× 253 1.8× 218 1.8× 50 0.7× 45 0.7× 42 549
Nicola Stefano Fracchiolla Italy 16 254 1.7× 107 0.8× 82 0.7× 80 1.1× 19 0.3× 42 744
Giada Maria Vecchio Italy 18 184 1.2× 258 1.8× 51 0.4× 140 1.8× 68 1.0× 51 729
Zana Brkić Netherlands 11 138 0.9× 274 2.0× 297 2.4× 137 1.8× 50 0.7× 17 743
J.M. van Laar Netherlands 11 36 0.2× 232 1.7× 207 1.7× 50 0.7× 30 0.4× 23 492
Hülya Bükülmez United States 12 196 1.3× 157 1.1× 76 0.6× 23 0.3× 51 0.7× 24 550
Kamran Alimoghadam Iran 12 92 0.6× 36 0.3× 112 0.9× 35 0.5× 32 0.5× 23 430

Countries citing papers authored by Qingran Yan

Since Specialization
Citations

This map shows the geographic impact of Qingran Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingran Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingran Yan more than expected).

Fields of papers citing papers by Qingran Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingran Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingran Yan. The network helps show where Qingran Yan may publish in the future.

Co-authorship network of co-authors of Qingran Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Qingran Yan. A scholar is included among the top collaborators of Qingran Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingran Yan. Qingran Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Qingfeng, Tong Wang, Xu Ouyang, et al.. (2025). Effectiveness of Acupuncture for Neck Pain: Systematic Review and Meta‑analysis with Trial Sequential Analysis. Journal of Pain Research. Volume 18. 6297–6316.
2.
3.
Cen, Han, Qingran Yan, Tao Meng, et al.. (2023). Quantitative infrapatellar fat pad signal intensity alteration as an imaging biomarker of knee osteoarthritis progression. RMD Open. 9(1). e002565–e002565. 12 indexed citations
4.
Yan, Qingran, et al.. (2023). Iguratimod as an alternative therapy for systemic sclerosis and prevention of the occurrence of ischemic digital ulcer. Frontiers in Medicine. 10. 1113408–1113408. 1 indexed citations
5.
Zhang, Zhiliang, Qiong Fu, Chunde Bao, et al.. (2023). Iguratimod attenuated fibrosis in systemic sclerosis via targeting early growth response 1 expression. Arthritis Research & Therapy. 25(1). 151–151. 3 indexed citations
6.
Distler, Oliver, Xiaojiang Xu, Qianqian Li, et al.. (2023). Endothelial Response to Type I Interferon Contributes to Vasculopathy and Fibrosis and Predicts Disease Progression of Systemic Sclerosis. Arthritis & Rheumatology. 76(1). 78–91. 16 indexed citations
7.
Yan, Qingran, Mei Zhang, Fang Du, et al.. (2023). Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study. Frontiers in Immunology. 14. 1062919–1062919. 1 indexed citations
8.
Cen, Han, Qingran Yan, Weiyu Han, et al.. (2022). Longitudinal association of infrapatellar fat pad signal intensity alteration with biochemical biomarkers in knee osteoarthritis. Lara D. Veeken. 62(1). 439–449. 12 indexed citations
9.
Yan, Qingran, Bei Liu, Minjie Yang, et al.. (2022). Duration biased distribution of clinical and immunological phenotypes in active SLE. Frontiers in Immunology. 13. 1044184–1044184. 1 indexed citations
10.
11.
Li, Rui, et al.. (2020). Understanding Fibrosis in Systemic Sclerosis: Novel and Emerging Treatment Approaches. Current Rheumatology Reports. 22(11). 77–77. 4 indexed citations
12.
13.
Yan, Qingran, Qiong Fu, Ran Wang, et al.. (2020). Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study. Arthritis Research & Therapy. 22(1). 65–65. 14 indexed citations
14.
Yan, Ye, Mei Liu, Fang Du, et al.. (2019). Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Research & Therapy. 21(1). 92–92. 36 indexed citations
15.
Yan, Qingran, et al.. (2019). FRI0216 IGURATIMOD MIGHT BE AN ALTERNATIVE OPTION FOR REFRACTORY LUPUS NEPHRITIS: A PRELIMINARY OBSERVATIONAL STUDY. Annals of the Rheumatic Diseases. 78. 787–788. 2 indexed citations
16.
Chen, Jie, Shuhui Sun, Qingran Yan, Chunde Bao, & Qiong Fu. (2016). Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study. Clinical Rheumatology. 35(2). 333–340. 12 indexed citations
17.
Yan, Qingran, et al.. (2016). Targeting miR-155 to Treat Experimental Scleroderma. Scientific Reports. 6(1). 20314–20314. 62 indexed citations
18.
Gao, Kun, Xiaofeng Jin, Jian Ma, et al.. (2015). Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover. Cell Death and Disease. 6(3). e1687–e1687. 50 indexed citations
19.
Yan, Qingran, Fang Du, Xinfang Huang, et al.. (2014). Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL/lpr Mice. PLoS ONE. 9(10). e108273–e108273. 27 indexed citations
20.
Wang, Xiaodong, Xinfang Huang, Qingran Yan, & Chunde Bao. (2014). Aberrant Activation of the WNT/β-Catenin Signaling Pathway in Lupus Nephritis. PLoS ONE. 9(1). e84852–e84852. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Adele Lonati Breakdown of academic impact, for papers by Stinne Ravn Greisen Breakdown of academic impact, for papers by Tatjana Terzić Breakdown of academic impact, for papers by Ryo Hisada Breakdown of academic impact, for papers by Nicola Stefano Fracchiolla Breakdown of academic impact, for papers by Giada Maria Vecchio Breakdown of academic impact, for papers by Zana Brkić Breakdown of academic impact, for papers by J.M. van Laar Breakdown of academic impact, for papers by Hülya Bükülmez Breakdown of academic impact, for papers by Kamran Alimoghadam
Rankless by CCL
2026